Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.530
+0.170 (7.20%)
At close: Nov 20, 2024, 4:00 PM
2.615
+0.085 (3.36%)
After-hours: Nov 20, 2024, 5:20 PM EST
Sana Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 67.55 | 73.3 | 58.36 | 50.41 | 28.27 | 21.78 | |
| Research & Development | 229.22 | 253.6 | 204.37 | 274.66 | 232.09 | 101.52 | |
| Operating Expenses | 296.76 | 326.9 | 262.73 | 325.07 | 260.36 | 123.29 | |
| Operating Income | -296.76 | -326.9 | -262.73 | -325.07 | -260.36 | -123.29 | |
| Interest & Investment Income | 11.54 | 9.94 | 3.76 | 0.68 | 0.75 | 2.86 | |
| Other Non Operating Income (Expenses) | -4.87 | -0.05 | -0.67 | 0.31 | 0.1 | -0.03 | |
| EBT Excluding Unusual Items | -290.09 | -317.01 | -259.64 | -324.09 | -259.51 | -120.47 | |
| Merger & Restructuring Charges | - | - | -8.7 | - | - | - | |
| Asset Writedown | -7.01 | -7.01 | -4.5 | - | - | - | |
| Other Unusual Items | -8.7 | 40.77 | 3.36 | -31.84 | -25.79 | -17.86 | |
| Pretax Income | -305.81 | -283.26 | -269.48 | -355.93 | -285.31 | -138.33 | |
| Income Tax Expense | - | - | - | - | - | -7.55 | |
| Net Income | -305.81 | -283.26 | -269.48 | -355.93 | -285.31 | -130.78 | |
| Net Income to Common | -305.81 | -283.26 | -269.48 | -355.93 | -285.31 | -130.78 | |
| Shares Outstanding (Basic) | 221 | 195 | 188 | 166 | 13 | 5 | |
| Shares Outstanding (Diluted) | 221 | 195 | 188 | 166 | 13 | 5 | |
| Shares Change (YoY) | 14.69% | 3.29% | 13.17% | 1178.88% | 165.43% | 415.02% | |
| EPS (Basic) | -1.38 | -1.46 | -1.43 | -2.14 | -21.92 | -26.67 | |
| EPS (Diluted) | -1.38 | -1.46 | -1.43 | -2.14 | -21.92 | -26.67 | |
| Free Cash Flow | -274.99 | -273.61 | -310.93 | -280.92 | -161.85 | -111.64 | |
| Free Cash Flow Per Share | -1.24 | -1.41 | -1.65 | -1.69 | -12.44 | -22.77 | |
| EBITDA | -273.8 | -302.34 | -247.1 | -314 | -254.44 | -121.47 | |
| D&A For EBITDA | 22.96 | 24.56 | 15.63 | 11.07 | 5.92 | 1.83 | |
| EBIT | -296.76 | -326.9 | -262.73 | -325.07 | -260.36 | -123.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.